Sign Up Today and Learn More About Circle Pharma Stock
Invest in or calculate the value of your shares in Circle Pharma or other pre-IPO companies through EquityZen's platform.
Circle Pharma Stock (CIRP)
Circle Pharma is a provider of a macrocycle development platform intended to provide macrocyclic peptides.
About Circle Pharma Stock
Founded
2012
Headquarters
San Francisco, CA, US
Industries
Professional Services, Sales and Marketing, Food and Beverage
Circle Pharma Press Mentions
Stay in the know about the latest news on Circle Pharma
Circle Pharma Announces Participation in Upcoming Investor Conferences
businesswire • Nov 04, 2025
Circle Pharma Appoints Rob Lauzen as Chief Financial Officer
businesswire • Nov 03, 2025
Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
biospace • Oct 25, 2025
Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
businesswire • Oct 24, 2025
Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
morningstar • Oct 23, 2025
Circle Pharma Management
Leadership team at Circle Pharma
Board Member
Thilo Schroeder
Board Member
Peter Svennilson
Join now and verify your accreditation status to gain access to:
- Circle Pharma Current Valuation
- Circle Pharma Stock Price
- Circle Pharma Management
- Available deals in Circle Pharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Circle Pharma Cap Table and Funding History by Share Class and Liquidity Preferences
- Circle Pharma Revenue and Financials
- Circle Pharma Highlights
- Circle Pharma Business Model
- Circle Pharma Risk Factors
- Circle Pharma Research Report from SACRA Research
Trading Circle Pharma Stock
How to invest in Circle Pharma stock?
Accredited investors can buy pre-IPO stock in companies like Circle Pharma through EquityZen funds. These investments are made available by existing Circle Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Circle Pharma stock?
Shareholders can sell their Circle Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
